XtremeVRI develops a software called Alterniity designed to detect early signs of Alzheimer’s and dementia, and to retard the onset and progression of the disease.
Recently, our group produced very promising results on the value of a Virtual Reality psychomotor and cognitive stimulation environment for complex everyday activities assessment, which was evaluated as an early biomarker, compared to the established biomarkers, such as brain-scanning of event related potentials (ERPs), magnetic resonance imaging (MRI) or neuropsychological tests regarding it’s predictive value in patients at risk of developing AD in the near future (Tarnanas et al, 2014). In addition to early screening, VR has also proven beneficial as a form of brain training for the rehabilitation of the cognitive decline at the very early stages of dementia. In conclusion, the “potential for change” of this project is to develop a novel tool that will provide therapists with an innovative means of dealing with cognitive rehabilitation and offer patients customized rehabilitation sessions, on the basis of simulated iADL. Tarnanas, I., Tsolaki, M., Nef, T., Muri, R., & Mosimann, U. P. (2014). Can a novel computerized cognitive screening test provide additional information for early detection of Alzheimer Disease? Alzheimer’s & Dementia : The Journal of the Alzheimer's Association.